UNIVERSAL HEALTH SERVICES INC UHS

Healthcare SIC 8062 - Services-General Medical & Surgical Hospitals, NEC NAICS Health Care and Social Assistance › Hospitals › General Medical and Surgical Hospitals derived NYSE

Our principal business is owning and operating, through our subsidiaries, acute care hospitals and outpatient facilities and behavioral health care facilities.

As of February 25, 2026, we owned and/or operated 375 inpatient facilities and 168 outpatient and other facilities located in 40 states, Washington, D.C., the United Kingdom and Puerto Rico. We have changed the method of our outpatient behavioral health care facility counts during the third quarter of 2025 and substantially all of the increase from prior periods is related to that change in convention.

•13 outpatient centers & 1 surgical hospital.

Behavioral health care facilities (346 inpatient facilities and 119 outpatient facilities):

Last close 186.89 2026-10-23
Market cap $11.15B estimated share count
52-week range 140.08 - 246.32

Valuation FY2025 figures against the last close

P/S0.6x
P/E8.1x
P/FCF13.1x
EV/EBITDA6.1x
Dividend yield0.5%
Diluted EPS23.10

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $17.36B$15.83B$14.28B$13.40B$12.64B$11.56B$11.38B$10.77B$10.41B$9.77B
Total operating expenses $15.37B$14.15B$13.11B$12.40B$11.28B$10.20B$10.16B$9.60B$9.13B$8.48B
Operating income $1.99B$1.68B$1.18B$1.00B$1.36B$1.36B$1.22B$1.18B$1.28B$1.28B
Interest expense $156.1M$186.1M$206.7M$126.9M$83.7M$106.3M$162.7M$155.0M$145.2M$125.1M
Pre-tax income $1.97B$1.50B$940.4M$866.3M$1.29B$1.25B$1.07B$1.03B$1.14B$1.16B
Income tax $461.0M$334.8M$221.1M$209.3M$305.7M$299.3M$238.8M$236.6M$363.7M$409.2M
Net income $1.51B$1.16B$719.3M$657.0M$987.6M$944.0M$814.9M$779.7M$752.3M$702.4M
EPS, basic 23.4217.1610.359.2311.9911.069.168.357.867.22
EPS, diluted 23.1016.8210.239.1411.8210.999.138.317.817.14
Shares, diluted (wtd. avg.) 64.5M67.9M70.1M73.8M83.7M85.6M89.0M93.8M96.3M98.4M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $137.8M$126.0M$119.4M$102.8M$115.3M$1.22B$61.3M$105.2M$74.4M$33.7M
Receivables $2.60B$2.18B$2.24B$2.02B$1.75B$1.73B$1.56B$1.51B$1.50B$1.44B
Total current assets $3.41B$2.82B$2.81B$2.54B$2.26B$3.28B$1.92B$1.94B$1.80B$1.68B
Property, plant and equipment $7.01B$6.57B$6.12B$5.92B$5.87B$5.37B$5.02B$4.85B$4.57B$4.33B
Goodwill $3.99B$3.93B$3.93B$3.91B$3.96B$3.88B$3.87B$3.84B$3.83B$3.78B
Other intangibles $75.9M$76.3M$77.0M$78.1M$81.0M$82.6M$83.7M$173.0M$220.0M$228.0M
Total assets $15.53B$14.47B$13.97B$13.49B$13.09B$13.48B$11.67B$11.27B$10.76B$10.32B
Accounts payable $750.1M$632.0M$614.0M$636.6M$658.9M$570.5M$447.0M$445.7M$442.0M$439.7M
Short-term debt $748.2M$40.1M$126.7M$81.4M$48.4M$332.0M$87.5M$63.4M$545.6M$105.9M
Total current liabilities $3.24B$2.21B$2.01B$1.91B$1.98B$2.48B$1.56B$1.45B$1.85B$1.32B
Long-term debt $4.00B$4.46B$4.79B$4.73B$4.14B$3.52B$3.90B$3.94B$3.49B$4.03B
Retained earnings $7.99B$7.37B$6.80B$6.53B$6.60B$6.75B$5.93B$5.79B$5.35B$4.89B
Total equity $7.28B$6.67B$6.20B$5.97B$6.19B$6.40B$5.58B$5.47B$5.05B$4.60B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $1.86B$2.07B$1.27B$996.0M$883.7M$2.36B$1.44B$1.27B$1.25B$1.33B
Depreciation and amortisation $594.0M$559.6M$535.6M$544.0M$501.6M$478.8M$455.6M$410.0M$388.4M$350.8M
Stock-based compensation $95.7M$99.3M$87.7M$85.4M$73.7M$65.8M$69.4M$66.6M$56.7M$48.1M
Capital expenditure $1.02B$943.8M$743.1M$734.0M$855.7M$731.3M$634.1M$665.0M$557.5M$519.9M
Investing cash flow -$1.07B-$911.1M-$763.3M-$647.3M-$914.5M-$802.6M-$688.4M-$747.2M-$684.7M-$1.16B
Financing cash flow -$749.7M-$1.14B-$493.9M-$318.4M-$1.07B-$384.9M-$845.0M-$492.2M-$519.2M-$171.2M
Dividends paid $51.3M$53.3M$55.5M$58.4M$65.9M$17.3M$53.0M$37.3M$38.2M$38.9M
Buybacks $968.0M$670.8M$547.4M$832.9M$1.22B$206.7M$770.5M$397.4M$364.4M$353.4M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-148814.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 5B 10B 15B 20B Revenue, FY2016: 9.8B Net income, FY2016: 702.4M Revenue, FY2017: 10.4B Net income, FY2017: 752.3M Revenue, FY2018: 10.8B Net income, FY2018: 779.7M Revenue, FY2019: 11.4B Net income, FY2019: 814.9M Revenue, FY2020: 11.6B Net income, FY2020: 944M Revenue, FY2021: 12.6B Net income, FY2021: 987.6M Revenue, FY2022: 13.4B Net income, FY2022: 657M Revenue, FY2023: 14.3B Net income, FY2023: 719.3M Revenue, FY2024: 15.8B Net income, FY2024: 1.2B Revenue, FY2025: 17.4B Net income, FY2025: 1.5B FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $9.77B $10.41B $10.77B $11.38B $11.56B $12.64B $13.40B $14.28B $15.83B $17.36B
Gross profit — — — — — — — — — —
Net income $702.4M $752.3M $779.7M $814.9M $944.0M $987.6M $657.0M $719.3M $1.16B $1.51B

Recent filings and events

  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • New debt or obligation Item 2.03
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Material agreement signed Item 1.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Material agreement signed Item 1.01
  • New debt or obligation Item 2.03
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Results announced Item 2.02
  • Material agreement signed Item 1.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 8062

TickerCompanyMarket capP/ERevenue growth
HCA HCA Healthcare, Inc. $104.05B 16.6x 7.1%
THC TENET HEALTHCARE CORP $21.62B 17.3x 3.1%
SGRY Surgery Partners, Inc. $2.06B — 6.2%
ARDT Ardent Health, Inc. $1.73B 12.8x 6.0%
CYH COMMUNITY HEALTH SYSTEMS INC $411.7M 0.8x -1.2%